Abstract:Objective To Observe dynamically the level of CD_4~+ CD_(25)~+ Tregs in the peripheral blood in patients with liver failure receiving artificial liver support system and/or medical treatment and investigate the relationship between the level of CD_4~+ CD_(25)~+ Tregs and curative effect and prognosis.Methods Sixty-three patients with liver failure were divided into 2 groups according to the treatment protocol:medical treatment combined with artificial liver support system(combined group)(29 cases)and medical treatment only group (medical group)(34 cases).According to indicators such as liver function and clinical symptoms etc,there were 17 effective cases and 12 ineffective cases in the combined group while 11 effective cases and 23 ineffective cases in the medical group.23 healthy donors were used as normal control group.The level of CD_4~+ CD_(25)~+ Treg in the peripheral blood was measured by flow cytometry dynamically and the relationship between the level of CD_4~+ CD_(25)~+ Treg and curative effect was analyzed accordingly.Results The Treg level was(2.46±0.56)% in the normal control group.For those effective groups,the Treg level before treatment was lower compared to normal control group,it was(1.92±0.78)% and(2.10±0.56)% in combined group and medical group respectively.There was no significant difference between these two groups (P0.05)although it was statistically significant when both compared to the normal control group(P 0.05);After treatment,the Treg level in the effective groups was(2.62±0.67)%(combined group)and (2.89±0.72)%(medical group)respectively.There was significant difference between these two groups (P0.05)while no statistical significant was found when compared to the normal control group(P 0.05);Both effective groups showed significant difference before and after the treatment(P0.05);As to the ineffective groups,the Treg level was higher before treatment compared to the normal control.It was (4.64±1.31)%(combined group)and(4.87±2.86)%(medical group)respectively.There was no significant difference between these two groups(P0.05)while it was statistical significant when compared to the normal control group(P0.05);After treatment the Treg level in the ineffective groups was(5.44± 2.13)%(combined group)and(5.91±2.78)%(medical group)respectively.There was no significant difference between these two groups(P0.05)although it was statistically significant compared to the normal control group(P0.05).There was significant difference before and after the treatment in both ineffective groups(P0.05).The change of Treg level appeared to show low-high-low peaked curve in the effective groups and it recovered to the normal level soon in the combined group compared to the medical treatment group.In the ineffective treatment groups,the change of Treg level appeared to be high-low-high notched curve.Conclusion The level of CD_4~+ CD_(25)~+ Treg was correlated with the curative effect and it may be used as a potential indicator for curative effect and prognosis in patients with liver failure.

The Clinical Relationship Between Presence of Peripheral Blood Regulatory T Cells and Hepatocellular Carcinoma and the Influence of Liver Resection on the Presence of Regulatory T Cells

Impact of increased CD4+ CD25+ FOXP3+ regulatory T cells on tumor recurrence in liver transplantation for hepatocellular carcinoma

[The Frequency, Phenotypes and Functions of CD4+ CD25+ Regulatory T Cells in Hepatocellular Carcinoma Patients].

Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma

An Investigation on Relationship Between the Level of CD4+ CD25+ Regulatory T Cells in the Peripheral Blood and Curative Effect in Patients with Liver Failure

Increased Cd4(+)Cd69(+)Cd25(-) T Cells In Patients With Hepatocellular Carcinoma Are Associated With Tumor Progression

Increased Prevalence of Regulatory T Cells in the Tumor Microenvironment and Its Correlation with TNM Stage of Hepatocellular Carcinoma.

ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis

Expression of T cells surface marker LAP in peripheral blood of hepatocellular carcinoma and its significance

Tumor Resection in Hepatic Carcinomas Restores Circulating T Regulatory Cells

Intratumoral Balance of Regulatory and Cytotoxic T Cells is Associated with Prognosis of Hepatocellular Carcinoma after Resection

Impact of Deviated Balance of Regulatory and Cytotoxic T Cells on Release and Reseeding of Circulating Tumor Cells in Hepatocellular Carcinoma.

The Unique Characteristic in Peripheral Immune Cells in Patients with Advanced Hepatocellular Carcinoma.

Intratumoral Regulatory T Cells with Higher Prevalence and More Suppressive Activity in Hepatocellular Carcinoma Patients

Intratumoral Regulatory T Cells Alone or in Combination with Cytotoxic T Cells Predict Prognosis of Hepatocellular Carcinoma after Resection.

Prognostic Significance of Regulatory T Lymphocytes in Patients with Hepatocellular Carcinoma

Study on the tumor infiltrating T lymphocytes subsets in HCC patients

Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues

The Value of Regular T and Memory T Lymphocytes in Analyzing Prognosis of HCC Without Portal Vein Invasion

Relationship Between PD-L1 Expression and CD8+ T-cell Immune Responses in Hepatocellular Carcinoma

Regulatory T Cells in Chronic Hepatitis B Patients Affect the Immunopathogenesis of Hepatocellular Carcinoma by Suppressing the Anti‐tumour Immune Responses